Ticker
RIGLCompany Name
RIGEL PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQ| Date | Earning Before Interest & Taxes (EBIT) | Interest Expense | Interest Coverage |
|---|---|---|---|
| 6/30/2025 | $ 106.88M | $ 7.74M | 13.8 |
| 3/31/2025 | $ 46.02M | $ 7.9M | 5.83 |
| 12/31/2024 | $ 26.28M | $ 7.92M | 3.32 |
| 9/30/2024 | $ 11.75M | $ 7.87M | 1.49 |
| 6/30/2024 | $ -6.52M | $ 7.71M | -0.85 |
| 3/31/2024 | $ -12.26M | $ 7.54M | -1.63 |
| 12/31/2023 | $ -18.22M | $ 6.87M | -2.65 |
| 9/30/2023 | $ -18.36M | $ 6.07M | -3.02 |
| 6/30/2023 | $ -32.77M | $ 5M | -6.56 |
| 3/31/2023 | $ -40.96M | $ 3.71M | -11.05 |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Int. Exp.
(=) Int. Coverage Int. Coverage for RIGEL PHARMACEUTICALS INC is calculated as follows: EBIT [ $ -26.46M ] / Int. Exp. [ $ 1.25M ]
(=) Int. Coverage [ -21.15 ] Minimum
Sep 30, 2020
Maximum
Jun 30, 2025
Average
Median
| filtered constituents | 2.37K |
|---|---|
| min | -25.49 |
| max | 28.75 |
| average | 2.16 |
| median | 2.09 |
| std | 8.45 |